Berner Industrier AB (STO:BERNER.B)

Akoya Biosciences Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	973.63	962.66	942.76	842	743.21	695.17
Revenue	973.63	962.66	942.76	842	743.21	695.17
Revenue Growth (YoY)	2.06%	2.11%	11.97%	13.29%	6.91%	-1.36%
Cost of Revenue	579.41	590.17	566.03	518.66	449.66	425.21
Gross Profit	394.22	372.49	376.73	323.35	293.55	269.96
Selling, General & Admin	291.11	283.78	276.34	256.4	238.32	207.02
Other Operating Expenses	-0.64	-0.41	0.34	-1.33	-0.76	-0.68
Operating Expenses	326.88	318.22	310.81	284.34	266.84	230.38
Operating Income	67.34	54.26	65.92	39	26.72	39.58
Interest Expense	-10.87	-11.14	-12.06	-6.67	-5.07	-3.81
Interest & Investment Income	3.37	2.42	2.06	0.25	0.13	0.16
Currency Exchange Gain (Loss)	-1.32	-1.32	-0.18	-1.35	0.66	0.01
Other Non Operating Income (Expenses)	-0.03	-0.03	-0.02	-	5.86	3.87
EBT Excluding Unusual Items	58.49	44.19	55.71	31.22	28.3	39.8
Gain (Loss) on Sale of Assets	2.77	2.77	2.18	0.57	0.47	0.02
Pretax Income	61.36	47.07	57.94	31.79	28.78	39.84
Income Tax Expense	13.91	10.21	12.55	7.45	6.05	8.72
Net Income	47.46	36.86	45.39	24.34	22.73	31.12
Net Income to Common	47.46	36.86	45.39	24.34	22.73	31.12
Net Income Growth	7.23%	-18.80%	86.47%	7.10%	-26.95%	-17.89%
Shares Outstanding (Basic)	19	19	19	19	19	19
Shares Outstanding (Diluted)	19	19	19	19	19	19
Shares Change (YoY)	0.23%	-	-	-0.00%	0.00%	0.45%
EPS (Basic)	2.53	1.96	2.42	1.30	1.21	1.66
EPS (Diluted)	2.53	1.96	2.42	1.30	1.21	1.66
EPS Growth	7.25%	-18.80%	86.47%	7.10%	-26.96%	-18.25%
Free Cash Flow	94.63	102.1	79	19.93	15.04	58.12
Free Cash Flow Per Share	5.03	5.44	4.21	1.06	0.80	3.10
Dividend Per Share	0.950	0.950	0.900	0.600	0.750	0.750
Dividend Growth	5.56%	5.56%	50.00%	-20.00%	-	25.00%
Gross Margin	40.49%	38.69%	39.96%	38.40%	39.50%	38.83%
Operating Margin	6.92%	5.64%	6.99%	4.63%	3.60%	5.69%
Profit Margin	4.87%	3.83%	4.81%	2.89%	3.06%	4.48%
Free Cash Flow Margin	9.72%	10.61%	8.38%	2.37%	2.02%	8.36%
EBITDA	73.3	60.07	72.3	44.07	31.46	44.03
EBITDA Margin	7.53%	6.24%	7.67%	5.23%	4.23%	6.33%
D&A For EBITDA	5.96	5.8	6.38	5.07	4.74	4.45
EBIT	67.34	54.26	65.92	39	26.72	39.58
EBIT Margin	6.92%	5.64%	6.99%	4.63%	3.60%	5.69%
Effective Tax Rate	22.66%	21.68%	21.66%	23.43%	21.02%	21.89%
Revenue as Reported	977.85	967.38	947.41	844.77	747.3	697.25

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.